Overall, 57% of participants had evidence on PET/MRI of inflammation affecting the heart or lungs.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
Of all participants, 59% had organ damage at 1 year—even those with non-severe infections.
People with asthma experienced worse control of their asthma after they had recovered from mild to moderate COVID-19.
Rates of COVID-19 rebound were similar in patients who did and didn't receive antiviral drugs, and relapse wasn't tied to worse clinical outcomes.
The WHO has abandoned plans for the second phase of its study into SARS-CoV-2 origins because of challenges it faced doing key studies in China.
COVID-19 may act as a disease accelerator, amplifying the risk of a diabetes diagnosis that may have come later in life.
The drug was linked to a reduced 28-day all-cause death rate and fewer emergency department visits for clinically significant relapse.
Antibiotic prescribing for upper respiratory tract infections increased in the 2 years after COVID-19 lockdown measures were implemented.
The consequences of sticking with current dogma included the loss of many lives and huge economic repercussions, experts say.
The XBB.1.5 subvariant is now dominant in most US regions as a decline in infections appears to be leveling off.
Death rates among unvaccinated people were 14 times those of bivalent vaccine recipients.
